omeprazole has been researched along with Protein-Losing Enteropathies in 9 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 5.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
| "Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 1.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groisman, GM | 1 |
| George, J | 1 |
| Berman, D | 1 |
| Harpaz, N | 1 |
| Muller, AF | 1 |
| Pinder, S | 1 |
| Toghill, PJ | 1 |
| Bayerdörffer, E | 1 |
| Ritter, MM | 1 |
| Hatz, R | 1 |
| Brooks, W | 1 |
| Ruckdeschel, G | 1 |
| Stolte, M | 1 |
| Gerosa, Y | 1 |
| Bernard, B | 1 |
| Lagneau, M | 1 |
| You, K | 1 |
| Hoang, C | 1 |
| Brasseur, JL | 1 |
| Opolon, P | 1 |
| Valla, D | 1 |
| Murata, I | 1 |
| Yoshikawa, I | 1 |
| Kuroda, T | 1 |
| Tabaru, A | 1 |
| Miura, T | 1 |
| Otsuki, M | 1 |
| Yamada, M | 1 |
| Sumazaki, R | 1 |
| Adachi, H | 1 |
| Ahmed, T | 1 |
| Matsubara, T | 1 |
| Hori, T | 1 |
| Nakahara, A | 1 |
| Takita, H | 1 |
| Ladas, SD | 1 |
| Tassios, PS | 1 |
| Malamou, HC | 1 |
| Protopapa, DP | 1 |
| Raptis, SA | 1 |
| Madsen, LG | 1 |
| Taskiran, M | 1 |
| Madsen, JL | 1 |
| Bytzer, P | 1 |
| Takeda, H | 1 |
| Nishise, S | 1 |
| Furukawa, M | 1 |
| Nagashima, R | 1 |
| Shinzawa, H | 1 |
| Takahashi, T | 1 |
9 other studies available for omeprazole and Protein-Losing Enteropathies
| Article | Year |
|---|---|
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; He | 1994 |
Juvenile gastric polyposis: reduction in blood- and protein-losing gastropathy with omeprazole.
Topics: Adult; Anemia, Hypochromic; Diagnosis, Differential; Female; Gastritis, Hypertrophic; Humans; Omepra | 1994 |
Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infecti | 1994 |
[Cystic lymphangioma of the duodenum revealed by digestive hemorrhage and associated with exudative enteropathy].
Topics: Aged; Duodenal Neoplasms; Gastrointestinal Hemorrhage; Humans; Jejunal Neoplasms; Kidney Neoplasms; | 1993 |
Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole.
Topics: Adult; Duodenitis; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Intest | 1996 |
Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chil | 1997 |
Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Ménétrier's disease.
Topics: Aged; Albumins; Biopsy; Fatal Outcome; Gastric Juice; Gastritis, Hypertrophic; Humans; Immunoglobuli | 1997 |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Hel | 1999 |
Fecal clearance of alpha1-antitrypsin with lansoprazole can detect protein-losing gastropathy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; alpha 1-Antitrypsin; Enzyme Inhibitors; Feces; Human | 1999 |